Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study

Autor: Bollinger,Anna, Stäuble,Céline K, Jeiziner,Chiara, Wiss,Florine M, Hersberger,Kurt E, Lampert,Markus L, Meyer zu Schwabedissen,Henriette E, Allemann,Samuel S

Publikováno v: Pharmacogenomics and Personalized Medicine.

Anna Bollinger,1 Céline K Stäuble,1,2 Chiara Jeiziner,1 Florine M Wiss,1,2 Kurt E Hersberger,1 Markus L Lampert,1,2 Henriette E Meyer zu Schwabedissen,1 Samuel S Allemann1 1Department of Pharmaceutical Sciences, University of Basel, Basel, Swit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dovemedicalp::122e3c0648f9b16900a273f8a908d9f8
https://www.dovepress.com/genotyping-of-patients-with-adverse-drug-reaction-or-therapy-failure-d-peer-reviewed-fulltext-article-PGPM

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report

Autor: Jeiziner,Chiara, Allemann,Samuel S, Hersberger,Kurt E, Meyer zu Schwabedissen,Henriette E

Publikováno v: Pharmacogenomics and Personalized Medicine.

Chiara Jeiziner,1 Samuel S Allemann,1 Kurt E Hersberger,1 Henriette E Meyer zu Schwabedissen2 1Pharmaceutical Care Research Group, Department Pharmaceutical Sciences, University of Basel, Basel, Switzerland; 2Biopharmacy, Department Pharmaceutical Sc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dovemedicalp::4e4773c4d6720a250a14df01ea8f9b5c
https://www.dovepress.com/is-pharmacogenetic-panel-testing-applicable-to-low-dose-methotrexate-i-peer-reviewed-fulltext-article-PGPM

HLA-associated adverse drug reactions - Scoping Review and Analysis of the Swiss Drug Labels

Autor: Jeiziner, Chiara, Wernli, Ursina, Meyer zu Schwabedissen, Henriette, Hersberger, Kurt E., Suter, Katja

Publikováno v: Nützliche patientenrelevante Forschung; 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin; 20200213-20200215; Basel, Schweiz; DOC20ebmPP6-04 /20200212/

Background/research question: Drug labels (DLs) provide information on genetic polymorphisms influencing drug safety and efficacy and instructions on pharmacogenetic (PGx) testing. No specific section is dedicated to PGx. However, the instructions on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b151a802282fd750f4863a5ef83664f1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.